Concert Pharmaceuticals, Inc. (CNCE) |
| 8.37 0 (0%) 03-03 16:00 |
| Open: | 8.38 |
| High: | 8.55 |
| Low: | 8.35 |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | -2.64 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 8.55 |
| Resistance 1: | 8.46 |
| Pivot price: | 8.37 |
| Support 1: | 8.31 |
| Support 2: | 6.91 |
| 52w High: | 8.55 |
| 52w Low: | 2.72 |
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Financials
| EPS | -3.170 |
| Book Value | 2.780 |
| PEG Ratio | 0.00 |
| Gross Profit | -1.145 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -287.97 |
| Return on Assets (ttm) | -38.5 |
| Return on Equity (ttm) | -108.7 |
Company news
Fri, 03 Feb 2023
Terran Biosciences secures intellectual property for psychedelic prodrugs - drugdiscoverytrends.com
Thu, 19 Jan 2023
Sun Pharma to Acquire Concert Pharmaceuticals - citybiz
Thu, 19 Jan 2023
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata - Business Wire
Tue, 14 Jun 2022
Trade Alert: The Co-Founder & Independent Chairman of the Board Of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), Richard Aldrich, Has Just Spent US$1m Buying 62% More Shares - Yahoo Finance
Tue, 02 Feb 2021
Concert Pharma craters as schizophrenia candidate flops - The Pharma Letter
Mon, 01 Feb 2021
Why Concert Pharmaceuticals Stock Cratered Today - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
